Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy

Recent unprecedented advances in treatment for spinal muscular atrophy (SMA) enabled patients to access the first approved disease modifying therapy for the condition. There are however many uncertainties, regarding timing of treatment initiation, response to intervention, treatment effects and long...

Descripción completa

Detalles Bibliográficos
Autores principales: Kariyawasam, Didu S. T., D'Silva, Arlene, Lin, Cindy, Ryan, Monique M., Farrar, Michelle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709682/
https://www.ncbi.nlm.nih.gov/pubmed/31481927
http://dx.doi.org/10.3389/fneur.2019.00898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709682/
https://www.ncbi.nlm.nih.gov/pubmed/31481927
http://dx.doi.org/10.3389/fneur.2019.00898

Ejemplares similares